Đang chuẩn bị liên kết để tải về tài liệu:
Retrospective analysis of the impact of platinum dose reduction and chemotherapy delays on the outcomes of stage III ovarian cancer patients

Đang chuẩn bị nút TẢI XUỐNG, xin hãy chờ

Ovarian cancer is a common gynaecological malignancy still remaining a challenge to treat. The objective of this study was to evaluate the impact of platinum dose reduction and chemotherapy delays on progression free survival and overall survival in patients with stage III ovarian cancer and to analyze reasons for such chemotherapy scheme modifications. |

TÀI LIỆU LIÊN QUAN

Pediatric high-impact conditions in the United States: Retrospective analysis of hospitalizations and associated resource use

Economic evaluation of the breast cancer screening programme in the Basque Country: Retrospective cost-effectiveness and budget impact analysis

Báo cáo y học: "Impact of methylphenidate formulation on treatment patterns and hospitalizations: a retrospective analysis"

The impact of neoadjuvant and adjuvant immunotherapy on the survival of pancreatic cancer patients: A retrospective analysis

The impact of KRAS mutations on prognosis in surgically resected colorectal cancer patients with liver and lung metastases: A retrospective analysis

The impact of care process development and comorbidity on time to surgery, mortality rate and functional outcome for hip fracture patients: A retrospective analysis over 19 years with data from the Swedish National Registry for hip fracture patients, RIKSHÖFT

Coding quality of deaths and its impact on elderly unintentional fall mortality data from 1990 to 2019: A retrospective analysis of the WHO Mortality Database

A propensity score-matched analysis of the impact of statin therapy on the outcomes of patients with non-small-cell lung cancer receiving anti-PD-1 monotherapy: A multicenter retrospective study

Analysis of the impact of platinum-based combination chemotherapy in small cell cervical carcinoma: A multicenter retrospective study in Chinese patients

Impact of the treatment of pancreatic exocrine insufficiency on survival of patients with unresectable pancreatic cancer: A retrospective analysis